CAS: 748146-89-6
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | WAY-383487 REF: IN-DA023ODECAS: 748146-89-6 | 95% | 159.00 €~609.00 € | Tue 06 May 25 |
 | CDK9-IN-30 REF: 54-BUP07642CAS: 748146-89-6 | ≥98% | 481.00 €~1,866.00 € | Mon 05 May 25 |
 | CDK9-IN-30 REF: TM-T9632CAS: 748146-89-6 | 99.76% | 56.00 €~1,378.00 € | Tue 13 May 25 |
Ref: IN-DA023ODE
| 10mg | 159.00 € | ||
| 25mg | 227.00 € | ||
| 50mg | 509.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
Ref: 54-BUP07642
| 25mg | 481.00 € | ||
| 50mg | 705.00 € | ||
| 100mg | 966.00 € | ||
| 500mg | 1,866.00 € |
Estimated delivery in United States, on Monday 5 May 2025
CDK9-IN-30
CAS:748146-89-6
CDK9-IN-30 is one of the Tat peptide derivatives and inhibits HIV-1 long terminal repeat-activated transcription.
Formula:
C16H20FNO3
Purity:
99.76%
Color and Shape:
Solid
Molecular weight:
293.33
Ref: TM-T9632
| 1mg | 56.00 € | ||
| 5mg | 119.00 € | ||
| 10mg | 187.00 € | ||
| 25mg | 316.00 € | ||
| 50mg | 472.00 € | ||
| 100mg | 658.00 € | ||
| 500mg | 1,378.00 € | ||
| 1mL*10mM (DMSO) | 114.00 € |
Estimated delivery in United States, on Tuesday 13 May 2025
